Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2015

Open Access 01-12-2015 | Case report

Spontaneous regression of non-small cell lung cancer after biopsy of a mediastinal lymph node metastasis: a case report

Authors: Alberto Lopez-Pastorini, Till Plönes, Michael Brockmann, Corinna Ludwig, Frank Beckers, Erich Stoelben

Published in: Journal of Medical Case Reports | Issue 1/2015

Login to get access

Abstract

Introduction

Spontaneous regression of cancer is defined as a complete or partial, temporary or permanent disappearance of tumor in the absence of specific therapy. With only a few cases reported, spontaneous regression is extremely rare in primary lung cancer. Regarding spontaneous regression in lung cancer, recent investigations revealed the role of immunological mechanisms, thus indicating potential treatment options by specific immunotherapy in the future.

Case presentation

A 76-year-old Caucasian man with progressive dyspnea presented to our hospital. A computed tomography scan revealed a tumor mass in the upper lobe of his right lung and enlarged mediastinal lymph nodes. A biopsy of a paratracheal lymph node by mediastinoscopy disclosed metastatic lung cancer. By immunohistochemical findings the tumor was classified as large cell carcinoma. Diagnosed with clinical stage IIIA non-small cell lung cancer, a neoadjuvant therapy concept was indicated. However, before starting chemoradiation, a computed tomography scan showed a regression of both the tumor mass in the upper lobe of his right lung and the mediastinal lymphadenopathy. As a repeated computed tomography scan showed further regression, we agreed with our patient to perform routine follow-up instead of starting therapy. To date, no relapse has been reported.

Conclusions

Given the circumstances that regression started after the biopsy and involved both the tumor in the upper lobe of his right lung and the mediastinal lymph node metastases, an immune response is a reasonable explanation for the observed spontaneous regression in this case.
Literature
1.
go back to reference Everson TC, Cole WH. Spontaneous regression of malignant disease. J Am Med Assoc.1959; 169:1758–9.CrossRefPubMed Everson TC, Cole WH. Spontaneous regression of malignant disease. J Am Med Assoc.1959; 169:1758–9.CrossRefPubMed
3.
4.
go back to reference Cole WH. Relationship of causative factors in spontaneous regression of cancer to immunologic factors possibly effective in cancer. J Surg Oncol. 1976; 8:391–411.CrossRefPubMed Cole WH. Relationship of causative factors in spontaneous regression of cancer to immunologic factors possibly effective in cancer. J Surg Oncol. 1976; 8:391–411.CrossRefPubMed
5.
go back to reference Kumar T, Patel N, Talwar A. Spontaneous regression of thoracic malignancies. Respir Med. 2010; 104:1543–50.CrossRefPubMed Kumar T, Patel N, Talwar A. Spontaneous regression of thoracic malignancies. Respir Med. 2010; 104:1543–50.CrossRefPubMed
6.
go back to reference Chang WY. Complete spontaneous regression of cancer: four case reports, review of literature, and discussion of possible mechanisms involved. Hawaii Med J. 2000; 59:379–87.PubMed Chang WY. Complete spontaneous regression of cancer: four case reports, review of literature, and discussion of possible mechanisms involved. Hawaii Med J. 2000; 59:379–87.PubMed
7.
go back to reference Sundar R, Cho BC, Brahmer JR, Soo RA. Nivolumab in NSCLC: latest evidence and clinical potential. Ther Adv Med Oncol.2015; 7(2):85-96. Sundar R, Cho BC, Brahmer JR, Soo RA. Nivolumab in NSCLC: latest evidence and clinical potential. Ther Adv Med Oncol.2015; 7(2):85-96.
8.
go back to reference Brahmer JR, Pardoll DM. Immune checkpoint inhibitors: making immunotherapy a reality for the treatment of lung cancer. CancerImmunol Res. 2013; 1(2):85-91. Brahmer JR, Pardoll DM. Immune checkpoint inhibitors: making immunotherapy a reality for the treatment of lung cancer. CancerImmunol Res. 2013; 1(2):85-91.
9.
go back to reference Rizvi NA, Hellmann MD, Snyder A, Kvistborg P, Makarov V, Havel JJ et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science. 2015; 348(6230):124-8. Rizvi NA, Hellmann MD, Snyder A, Kvistborg P, Makarov V, Havel JJ et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science. 2015; 348(6230):124-8.
10.
go back to reference Schneider T, Kimpfler S, Warth A, Schnabel PA, Dienemann H, Schadendorf D, et al. Foxp3(+) regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adenocarcinoma. J Thorac Oncol. 2011; 6:432–8.CrossRefPubMed Schneider T, Kimpfler S, Warth A, Schnabel PA, Dienemann H, Schadendorf D, et al. Foxp3(+) regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adenocarcinoma. J Thorac Oncol. 2011; 6:432–8.CrossRefPubMed
11.
go back to reference Iwakami S, Fujii M, Ishiwata T, Iwakami N, Hara M, Ihara H, et al. Small-cell lung cancer exhibiting spontaneous regression. Intern Med. 2013; 52:2249–52.CrossRefPubMed Iwakami S, Fujii M, Ishiwata T, Iwakami N, Hara M, Ihara H, et al. Small-cell lung cancer exhibiting spontaneous regression. Intern Med. 2013; 52:2249–52.CrossRefPubMed
12.
go back to reference Isobe M, Eikawa S, Uenaka A, Nakamura Y, Kanda T, Kohno S, et al. Correlation of high and decreased NY-ESO-1 immunity to spontaneous regression and subsequent recurrence in a lung cancer patient. Cancer Immun. 2009; 9:8.PubMedPubMedCentral Isobe M, Eikawa S, Uenaka A, Nakamura Y, Kanda T, Kohno S, et al. Correlation of high and decreased NY-ESO-1 immunity to spontaneous regression and subsequent recurrence in a lung cancer patient. Cancer Immun. 2009; 9:8.PubMedPubMedCentral
13.
go back to reference Challis GB, Stam HJ. The spontaneous regression of cancer. A review of cases from 1900 to 1987. Acta Oncol. 1990; 29:545–50.CrossRefPubMed Challis GB, Stam HJ. The spontaneous regression of cancer. A review of cases from 1900 to 1987. Acta Oncol. 1990; 29:545–50.CrossRefPubMed
14.
go back to reference Cole WH. Spontaneous regression of cancer: the metabolic triumph of the host? Ann N Y Acad Sci. 1974; 230:111–41.CrossRefPubMed Cole WH. Spontaneous regression of cancer: the metabolic triumph of the host? Ann N Y Acad Sci. 1974; 230:111–41.CrossRefPubMed
Metadata
Title
Spontaneous regression of non-small cell lung cancer after biopsy of a mediastinal lymph node metastasis: a case report
Authors
Alberto Lopez-Pastorini
Till Plönes
Michael Brockmann
Corinna Ludwig
Frank Beckers
Erich Stoelben
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2015
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-015-0702-9

Other articles of this Issue 1/2015

Journal of Medical Case Reports 1/2015 Go to the issue